Term ends Jun 6, 2031 · High confidence
20-year base term ends Dec 21, 2029
Held by Roche Diabetes Care, Inc.
Filed Dec 21, 2009 as application 12/643,415 · Granted May 23, 2017
Base term plus 532 days of patent term adjustment (USPTO delay)
Today
2009
2031
Clock starts
Dec 21, 2009
Dec 21, 2009
Term ends
Jun 6, 2031
Jun 6, 2031
Granted
May 23, 2017
May 23, 2017
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
532
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,437,962, to Jun 6, 2031. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
20
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 532 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 21, 2009, when this application, 12/643,415, was filed | Dec 21, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +532 days, USPTO patent term adjustment record | Jun 6, 2031 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,437,962) | resolves to Jun 6, 2031, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 6, 2031 | High confidence |
This family
| US 9,659,037 | this patent Jun 2031 | Jun 2031 |
| US 10,565,170 | Lapsed on the fee record Feb 2024 | Feb 2024 |
| US 10,437,962 | In force Mar 2032 | Mar 2032 |
| US 9,918,635 | In force Feb 2030 | Feb 2030 |
| US 10,456,036 | In force Sep 2031 | Sep 2031 |
| US 8,849,458 | Lapsed on the fee record Sep 2022 | Sep 2022 |
| Application 12/974,859 | Abandoned not computed | not computed |
| Application PCT/US2010/061573 | PCT application no patent term | no patent term |
8 of 20 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 11, 2010 Reel 24363, frame 269 | Soni, Abhishek S.; Weinert, Stefan; Walling, P. Douglas | Roche Diagnostics Operations, Inc. | Assignment of Assignor's Interest |
| May 11, 2010 Reel 24363, frame 281 | Rasch-menges, Juergen | Roche Diagnostics GmbH | Assignment of Assignor's Interest |
| May 11, 2010 Reel 24363, frame 302 | Roche Diagnostics GmbH | Roche Diagnostics Operations, Inc. | Assignment of Assignor's Interest |
| Jan 21, 2011 Reel 25678, frame 89 | Bousamra, Steven | Roche Diagnostics Operations, Inc. | Assignment of Assignor's Interest |
| Jan 17, 2012 Reel 27539, frame 947 | Greenburg, Alan M. | Roche Diagnostics Operations, Inc. | Assignment of Assignor's Interest |
| Jun 23, 2015 Reel 36008, frame 670 | Roche Diagnostics Operations, Inc. | Roche Diabetes Care, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2031
Term ends Jun 6, 2031. Maintenance fees still fall due before then
Note
The 532 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,437,962, ends no earlier than this term, so it caps nothing.
Citations
174
later US patents cite this one
That is top 5% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.